The Discounted Cash Flow (DCF) valuation of ACADIA Pharmaceuticals Inc (ACAD) is (17.38) USD. With the latest stock price at 18.53 USD, the upside of ACADIA Pharmaceuticals Inc based on DCF is -193.8%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.3% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (39.41) - (11.16) | (17.38) |
| Upside | -312.7% - -160.2% | -193.8% |